Strategies of empiric antibiotic therapy in severe sepsis

Area of Science:

• Critical care medicine
• Infectious diseases
• Antimicrobial stewardship

Background:

• Severe sepsis and septic shock are primary causes of mortality and multiple organ failure in surgical intensive care units.
• Rising antimicrobial resistance, particularly Gram-negative pathogens like Klebsiella pneumoniae and Pseudomonas aeruginosa, complicates early antibiotic treatment.
• Effective management necessitates updated therapeutic strategies.

Purpose of the Study:

• To provide comprehensive recommendations for treating diverse infections.
• To emphasize optimal empiric antibiotic therapy selection in early sepsis and localized infections.
• To address the challenge of multidrug-resistant organisms.

Main Methods:

• Literature review of current guidelines and research on sepsis and antimicrobial resistance.
• Analysis of treatment strategies for common Gram-negative pathogens.
• Discussion of empiric antibiotic selection criteria.

Main Results:

• Gram-negative bacteria, including Klebsiella pneumoniae and Pseudomonas aeruginosa, are leading pathogens in severe sepsis.
• Empiric antibiotic therapy must account for local resistance patterns.
• Early and appropriate antibiotic administration is crucial for patient outcomes.

Conclusions:

• Updated recommendations are essential for managing sepsis in the era of antimicrobial resistance.
• Tailoring empiric antibiotic therapy based on likely pathogens and resistance is critical.
• Continued surveillance and stewardship are necessary to combat multidrug-resistant infections.